Effect of pertussis toxin on the induction of nitric oxide synthesis in murine macrophages and on protection in vivo

Vaccine

Volumn 18, Issue 20, 2000, Pages 2110-2119

  Xing, D K L ^a   Canthaboo, C ^a   Corbel, M J ^a  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

Bordetella pertussis; Macrophage activation; Pertussis toxin; Vaccine

Indexed keywords

BACTERIAL ANTIGEN; NITRIC OXIDE; PERTUSSIS TOXIN; PERTUSSIS VACCINE;

AEROSOL; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DETOXIFICATION; FEMALE; IMMUNIZATION; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTECTION; PROVOCATION TEST;

ADHESINS, BACTERIAL; AEROSOLS; ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BORDETELLA PERTUSSIS; BRAIN; CELLS, CULTURED; DNA-BINDING PROTEINS; FEMALE; HEMAGGLUTININS; INJECTIONS; LUNG; MACROPHAGE ACTIVATION; MACROPHAGES, PERITONEAL; MICE; NITRIC OXIDE; PERTUSSIS TOXIN; PERTUSSIS VACCINE; REPRESSOR PROTEINS; SPECIFIC PATHOGEN-FREE ORGANISMS; VACCINATION; VIRULENCE FACTORS, BORDETELLA; WHOOPING COUGH;

EID: 0034010709     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00562-9     Document Type: Article

References (33)

1. Weiss A.A., Hewlett E.L. Virulence factors of Bordetella pertussis. Annu. Rev. Microbiol. 40:1986;661-686.
2. Thomas M.G., Redhead K., Lambert H.P. Human serum antibody responses to Bordetella pertussis infection and pertussis vaccination. J. Infect. Dis. 159:1989;211-218.
3. Plotkin S., Cadoz M. An interpretation of the acellular pertussis vaccine trials. Abstracts of the acellular pertussis vaccine trails. 1996;National Institutes of Health Pertussis Conference, Washington, DC.
4. Hewlett E.L. Pertussis: current concepts of pathogenesis and prevention. Pediatr. Infect. Dis. J. 16:1997;S78-S84.
5. Adamson P.C., Wu T.C., Meade B.D., Rubin M., Manclark C.R., Pizzo P.A. Pertussis in a previously immunized child with human immunodeficiency virus infection. J. Pediatr. 115:1989;589-592.
6. Bromberg K., Tannis G., Steiner P. Detection of Bordetella pertussis associated with the alveolar macrophages of children with human immunodeficiency virus infection. Infect. Immun. 59:1991;4715-4719.
7. Mills K.H.G., Barnard A., Watkins J., Redhead K. Cell-mediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model. Infect. Immun. 61:1993;399-410.
8. Ryan M., Murphy G., Gothefors L., Nilsson L., Storsaeter J., Mills K.H.G. Bordetella pertussis respiratory infection in children is associated with preferential acivation of type 1 T helper cells. JID. 175:1997;1246-1250.
9. Xing D.K.L., Canthaboo C., Corbel M.J. Nitric oxide induction in murine macrophages and spleen cells by whole-cell Bordetella pertussis vaccine. Vaccine. 16:1998;16-23.
10. Mills K.H.G., Ryan M., Ryan E., Mahon B.P. A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis. Infect. Immun. 66:1998;594-602.
11. Scott P., Pearce E., Cheever A.W., Coffman R.L., Sher A. Role of cytokines CD4+ T-cell subsets in the regulation of parasite immunity and disease. Immunol. Rev. 112:1989;161-182.
12. Babior B.M. The respiratory burst of phagocytes. J. Clin. Invest. 73:1984;599-601.
13. Ding A.H., Nathan C.F., Stuehr D.J. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J. Immunol. 141:1988;2407-2412.
14. Munoz J.J. Action of pertussigen (pertussis toxin) on the host immune system in pathogenesis and immunity in pertussis. Wardlaw A.C., Parton R. Pathogenesis and immunity in pertussis. 1988;173-192 Wiley, Chichester.
15. Pittman M. The concept of pertussis as a toxin-mediated disease. Ped. Infect. Dis. 3:1984;467-486.
16. Black W.J., Munoz J., Peacock M.G., Schad P.A., Cowell J.L., Burchall J.J., Lim M., Kent A., Steinman L., Falkow S. ADP-Ribosyltransferase activity of pertussis toxin and immunomodulation by Bordetella pertussis. Science. 240:1988;656-659.
17. Munoz J.J., Arai H., Cole R.L. Mouse protecting and histamine-sensitizing activities of pertussigen and fimbrial hemagglutinin from Bordetella pertussis. Infect. Immun. 32:1981;243-250.
18. Munoz J.J., Peacock M.G. Role of pertussigen (pertussis toxin) on the mouse protective activity of vaccines made from Bordetella species. Microbiol. Immunol. 33:1989;341-355.
19. Robinson A., Irons L.I. Synergistic effect of Bordetella pertussis lymphocytosis promoting factor on protective activities of isolated Bordetella antigens in mice. Infect. Immun. 40:1983;523-528.
20. Robinson A., Funnell S.G.P. Potency testing of acellular pertussis vaccines. Vaccine. 10:1992;139-141.
21. Sato Y., Sato H., Izumiya K., Cowell J.C., Manclark C.R. Role of antibody to filamentous hemagglutinin and to leukocytosis promoting factor-hemagglutinin in immunity to pertussis. Robbins J.B., Hill J.C. Seminars in infectious diseases. 1982;380-385 Thieme-Stratton, New York.
22. Hewlett E.L., Sauer K.T., Myers G.A., Cowell J.L., Guerant R.L. Induction of a novel morphological response in Chinese hamster ovary cells by pertussis toxin. Infec. Immun. 40:1983;1198-1203.
23. Minobe S., Nawata M., Shigemori N., Watanabe T. Assay of endotoxin in human plasma using immobilized histidine, limulus amoebocyte lysate and chromogenic substrate. Eur. J. Chem. Clin. Biochem. 32:1994;797-803.
24. Torre D., Ferrario G., Bonetta G., Perversi L., Speranza F. In vitro and in vivo induction of nitric oxide by murine macrophages stimulated with Bordetella pertussis. FEMS Immunol. and Medical Microbiol. 13:1996;95-99.
25. Kendrick P., Eldering G., Dixon M.K., Lawson G.M. Mouse protection tests in the study of pertussis vaccine. A comparative series using the intracerebral route for challenge. Am. J. Public Health. 37:1947;803-810.
26. Xing D.K.L., Das R.G., Williams L., Canthaboo C., Tremmil J., Corbel M.J. An aerosol challenge model of Bordetella pertussis infection as a potential bioassay for acellular pertussis vaccines. Vaccine. 17:1999;565-576.
27. Amiel S.A. The effects of Bordetella pertussis vaccination on cerebral vascular permeability. Br. J. Exp. Pathol. 57:1976;653-662.
28. Gupta R.K., Saxena S.N., Sharma S.B., Ahuja S. Protection of mice inoculated with purified pertussis toxin and filamentous haemagglutinin against intracerebral challenge with live Bordetella pertussis. Vaccine. 8:1990;289.
29. Cameron J. Variation of B. pertussis. J. Pathol. Bacteriol. 94:1967;367-374.
30. Wardlaw A.C., Parton R. Pertussis vaccine. Easmon C.S.F., Jeljaszewicz J. Medical microbiology, vol. 2, immunization against bacterial disease. 1983;207-253 Academic Press, New York.
31. Leininger E., Ewanowich C.A., Bhargava A., Peppler M.S., Kenimer J.G., Brennan M.J. Comparative roles of the Arg-Gly-Asp sequence present in the Bordetella pertussis adhesins pertactin and filamentous hemagglutinin. Infect. Immun. 60:1992;2380-2385.
32. Ishibashi Y., Claus S., Relman D.A. Bordetella pertussis filamentous hemagglutinin interacts with a leukocyte signal transduction complex and stimulates bacterial adherence to monocyte CR3 (CD11b/CD18). J. Exp. Med. 180:1994;1225-1233.
33. Beckerman K.P., Rogers H.W., Corbett J.A., Schreiber R.D., McDaniel M.L., Unanue E.R. Release of nitric oxide during the T cell-independent pathway of macrophage activation. J. Immun. 150:1993;888-895.